drugset / Trial / NCT02769247

Efficacy of Intrauterine Lidocaine and Naproxen for Pain Control With Intrauterine Device Insertion

NCT02769247

RandomizedParallel-groupQuadruple-blindTreatment

Summary

To compare the efficacy of intrauterine lidocaine and oral naproxen sodium on discomfort and pain of patients undergoing intrauterine device insertion.

Timeline

Start
2014-06
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 2 % Other
Subject Lidocaine Other / unclassified 5 ml Other
Subject Naproxen Small molecule 375 mg Oral

Indications

No indication recorded.